A Nitroglycerin Lingual Spray warns the chest pain drug may not be dispensed properly from some pump devices, which could lead to the need for medical intervention for patients with…
The COVID-19 pandemic has caused an overall increase in blood pressure nationwide, putting more Americans at risk of strokes, heart attacks and other health problems, according to a new study.
Rinvoq will now carry label warnings on cancer and heart risks which were first discovered through a study of Xeljanz side effects.
Nearly 20% of hypertension patients are prescribed drugs which may raise their blood pressure even further, according to the findings of a new study.
A new study announced by Eli Lilly appears to suggest Olumiant, a rheumatoid arthritis drug, does not need the same label warnings for heart problems as Xeljanz, it's competitor.
A new study suggests the risk of heart problems linked to Xeljanz is similar across all other rheumatoid arthritis drugs belonging to the same class of medications.
The eczema cream Opzelura, made from the same active ingredient as Jakafi, is being investigated for texture issues as the entire class of drugs faces scrutiny over heart and cancer…
A new study raises questions about whether testosterone therapy actually increases the risk of blood clots in men with hypogonadism.
A new study suggests vaping with nicotine-based e-cigarettes can increase the risk of blood clots, potentially leading to heart attacks and strokes.
The FDA is requiring new label warnings for Xeljanz and similar drugs, following a review which revealed links between increased risks of heart attacks, strokes, blood clots, and lymphomas, as…